Last reviewed · How we verify

NCT05657587

Treatment of Shoulder Osteoarthritis

Status unknown Last updated 27 February 2023
What this trial tests

trial testing SPRINT PNS in Chronic Shoulder Pain in 20 participants. Status unknown.

Timeline
1 April 2022
Primary endpoint
31 December 2023
31 December 2023

Quick facts

Lead sponsorGramercy Pain Center
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment20
Start date1 April 2022
Primary completion31 December 2023
Estimated completion31 December 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Gramercy Pain Center

Who can join

21 and older, any sex, with Chronic Shoulder Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to learn if pain can be relieved by delivering small amounts of electricity ("electrical stimulation") to the nerves relaying sensory information to the shoulder. This study will use a device called Sprint PNS system. PNS stands for Peripheral Nerve Stimulation. This device is cleared by the FDA for up to 60 days of use for relief of chronic or acute pain.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Chronic Shoulder Pain

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05657587.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing